openPR Logo
Press release

Biomarker Discovery Outsourcing Services Market Expected to Hit USD 83.93 Billion by 2034, at a CAGR of 19.3%

05-13-2025 01:04 PM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Biomarker Discovery Outsourcing Services Market

Biomarker Discovery Outsourcing Services Market

The global biomarker discovery outsourcing services market was estimated to be valued at USD 14.40 billion in 2024. It is expected to reach USD 83.93 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 19.3% from 2025 to 2034.

Market Introduction
Currently majority of drug firms have not yet acquired the comprehensive range of adequately robust potential and capacity in these areas. They require support from external firms. The demand for services in genomics/proteomics research, biomarker identification, and companion diagnostics has been growing rapidly. This has led to the emergence of a new sector within the global pharmaceutical outsourcing industry.

Contract research organizations (CROs) and other specialized firms provide a range of services to pharmaceutical, biotechnology, and academic institutions. These services focus on identifying and validating biomarkers for various applications, including drug discovery and development, diagnostics, personalized medicine, and prognostics. The adoption for these services is increasing as the industry shifts toward precision medicine, personalized therapies, and the growing need for predictive and prognostic tools in healthcare.

Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/biomarker-discovery-outsourcing-services-market/request-for-sample

Prominent Companies in the Market
The market is consolidated and excessively competitive for both big and moderate firms in the industry. Some of the prominent players operating in the market include:
• Celerion
• Charles River Laboratories International, Inc.
• Eurofins Scientific
• Evotec
• Fujirebio Holdings Inc.
• GenScript ProBio
• ICON plc
• Laboratory Corporation of America Holdings (Labcorp)
• Parexel International (MA) Corporation
• Proteome Sciences
• Thermo Fisher Scientific Inc.
• WuXi AppTec

Biomarker Discovery Outsourcing Services Market Report Highlights
• By type, surrogate endpoints hold the largest market share. Surrogate endpoints serve as indirect measures representing clinical outcomes, enabling researchers to assess treatment efficacy and safety more efficiently during drug development.

• By therapeutic area, oncology dominates the biomarker discovery outsourcing services market, driven by the increasing prevalence of cancer and the growing adoption of biomarker-driven drug development. The use of biomarkers in early cancer detection, prognosis, and treatment selection enhances the segment's significance in clinical research.

• North America holds the largest market share. This dominance is driven by substantial R&D investments, a strong emphasis on precision medicine, and robust collaborations between pharmaceutical companies and contract research organizations (CROs).

• Asia Pacific is experiencing the highest biomarker discovery outsourcing services market CAGR. This rapid expansion is attributed to increasing pharmaceutical R&D activities, a surge in clinical trial operations, and cost-effective outsourcing solutions available in countries such as China and India.

Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/biomarker-discovery-outsourcing-services-market/request-for-discount-pricing

Market Dynamics
Growing Cases of Chronic Illnesses: The growing cases of chronic illnesses, such as cancer, have notably increased the demand for biomarker discovery outsourcing services. Biomarkers are important instruments in early disease detection, diagnosis, and monitoring, enabling healthcare providers to apply timely and targeted mediation. For instance, the American Cancer Society estimated that in 2022, approximated 1.9 million cancers were detected in the US, underscoring the growing prevalence of this illness. This drives the biomarker discovery outsourcing services market demand.

Inclination for Personalized Medicines: The move towards personalized medicines, which customizes medical treatment to personal genetic profiles and illness attributes, has elevated the demand for accurate and dependable biomarkers. Biomarkers are crucial in recognizing patient subgroups, forecasting therapeutic reactions, and observing treatment results, thus easing customized healthcare mediations.

Market Segmentation
The biomarker discovery outsourcing services market segmentation is based on type, therapeutic area, discovery phase, end use, and region.

Based on type, the surrogate endpoints segment holds the largest market share due to them serving as an incidental measure showcasing clinical outcomes, allowing researchers to examine treatment productivity.

Based on therapeutic area, the oncology segment holds a larger market share owing to the growing existence of cancer globally, which has boosted the demand for progressive biomarkers.

By Type Outlook (Revenue-USD Billion, 2020-2034)
• Predictive Biomarkers
• Prognostic Biomarkers
• Safety Biomarkers
• Surrogate Endpoints

By Therapeutic Area Outlook (Revenue-USD Billion, 2020-2034)
• Oncology
• Neurology
• Cardiology
• Autoimmune Diseases
• Others

By Discovery Phase Outlook (Revenue-USD Billion, 2020-2034)
• Biomarker Identification
• Biomarker Validation
• Biomarker Profiling
• Biomarker Panel Development
• Biomarker Selection

By End Use Outlook (Revenue-USD Billion, 2020-2034)
• Pharmaceutical Companies
• Biotechnology Companies
• Others

Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/biomarker-discovery-outsourcing-services-market
Geographical Analysis

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

More Trending Latest Reports by Polaris Market Research:
Osmometers Market
https://www.polarismarketresearch.com/industry-analysis/osmometers-market

Medical Waste Container Market
https://www.polarismarketresearch.com/industry-analysis/medical-waste-container-market

Hysteroscopes Market
https://www.polarismarketresearch.com/industry-analysis/hysteroscopes-market

Audiology Devices Market
https://www.polarismarketresearch.com/industry-analysis/global-audiology-devices-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biomarker Discovery Outsourcing Services Market Expected to Hit USD 83.93 Billion by 2034, at a CAGR of 19.3% here

News-ID: 4013201 • Views:

More Releases from Polaris Market Research & Consulting

Building Information Modeling (BIM) Market to Hit USD 21.06 Billion by 2034 | Rising at a CAGR of 10.3%
Building Information Modeling (BIM) Market to Hit USD 21.06 Billion by 2034 | Ri …
The building information modeling market is projected to grow from USD 7.92 billion in 2024 to USD 21.06 billion by 2034; it is expected to expand at a CAGR of 10.3% from 2025 to 2034. Global government mandates, supportive policies, and rising investments in smart city development are driving increased demand for BIM. Building Information Modeling Explanation Building information modeling, or BIM, is a digital process that involves creating and managing detailed,
Customer Relationship Management Market Set to Reach USD 198.10 Billion by 2034 with a CAGR of 11.5%
Customer Relationship Management Market Set to Reach USD 198.10 Billion by 2034 …
Customer Relationship Management Market The customer relationship management market size was valued at USD 66.85 billion in 2024. Looking forward, Polaris Market Research estimates the market to reach USD 198.10 billion by 2034, exhibiting a CAGR of 11.5% from 2025 to 2034. Customer relationship management, also called CRM, is a technology and strategy utilized by businesses to manage interactions with potential and current customers. It involves organizing, automating, and synchronizing sales, marketing,
Metaverse Market Forecasts Impressive Growth, Set to Reach USD 4,798.77 Billion by 2034 with a CAGR of 46.3%
Metaverse Market Forecasts Impressive Growth, Set to Reach USD 4,798.77 Billion …
Metaverse Market Polaris Market Research has released a market assessment report titled, Metaverse Market - Forecast, 2025-2034. Market Overview The metaverse market was valued at USD 107.01 billion in 2024 and is expected to grow significantly, reaching USD 4,798.77 billion by 2034, registering a robust CAGR of 46.3% from 2025 to 2034. The metaverse is a collective virtual space created by the convergence of physical and digital realities, where users can interact with each other
Crime Risk Report Market Projected to Reach USD 64.00 Billion by 2034, Growing at a CAGR of 21.2%
Crime Risk Report Market Projected to Reach USD 64.00 Billion by 2034, Growing a …
Crime Risk Report Market The crime risk report market size was valued at USD 9.38 billion in 2024, according to Polaris Market Research's latest analysis. With a compound annual growth rate (CAGR) of 21.2% during 2025-2034, the market is projected to grow to USD 64.00 billion by 2034. What Is A Crime Risk Report? The crime risk report market revolves around the creation and distribution of detailed reports that assess the likelihood of

All 5 Releases


More Releases for Biomarker

Brain Biomarker Market 2021 | Detailed Report
The Brain Biomarker research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Brain Biomarker research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving force. Get Free Sample PDF (including full
Global Biomarker Market 2021 : Clinical Diagnostic, Drug Discovery, Diagnostic B …
This "Biomarker Market" to portray important bits of knowledge identified with critical market patterns driving the business. The Biomarker report incorporates a scope of inhibitors just as main impetuses of the market which are broke down in both subjective and quantitative methodology so perusers and clients get exact data and experiences about industry. Factual information referenced in the report is represented with the assistance of diagrams which improves on the
Impact of Outbreak of Coronavirus (Covid-19) on Biomarker Technologies Market 20 …
The Biomarker Technologies market is expected to reach USD 92 Billion by 2027 from USD 60 Billion in 2019, at a CAGR of 10% during the forecast period. A comprehensive report on Biomarker Technologies Market was published by Research N Reports to understand the complete setup of Biomarker Technologies Market industries. Effective qualitative and quantitative analysis techniques have been used to examine the data accurately. Variable factors that comprise basis
Biomarker Technologies Market – Major Technology Giants in Buzz Again | Biomar …
A New Research on the Global Biomarker Technologies Market was conducted across a variety of industries in various regions to produce more than 150 page reports. This study is a perfect blend of qualitative and quantifiable information highlighting key market developments, industry and competitors' challenges in gap analysis and new opportunities and may be trending in the Biomarker Technologies market. Some are part of the coverage and are the core
Global Cancer Biomarker Market Advantages & Developments 2025
Qyresearchreports include new market research report "Global Cancer Biomarker Market Size,Status and Forecast 2025" to its huge collection of research reports. The global Cancer Biomarker market has been exclusively and elaborately examined in this report while taking into account some of the most pivotal factors holding the capability to influence growth. For the said forecast tenure, the report has shed light on critical market dynamics, which include trends, opportunities, restraints, and
Biomarker Technologies Market : Analysis & Trends 2025
A biomarker also known as biological marker is a gene, molecule or characteristic by which biological state of the body is measured in order to assess and predict a particular disease or some other physiological state of an individual. It helps clinicians in disease identification and effectively plan treatment process. Biomarkers are extensively applied for diagnosis and clinical decision making in various medical specialties including cancer, diabetes, cardiovascular and neurological